Skip to the page

Data / Drug companies / Emtricitabine and tenofovir disoproxil fumarate

Emtricitabine and tenofovir disoproxil fumarate: 28 companies and 48 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Emtricitabine and tenofovir disoproxil fumarate is listed in the FDA National Drug Code Directory by 28 companies, with 48 products in commercial distribution. 43 of the products (89.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on July 1, 2025.

The request: Get every company that lists emtricitabine and tenofovir disoproxil fumarate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
28
Products
48
Generic (ANDA) products
43 (89.6%)
Application numbers
12
Routes
Oral
Brand names
Truvada
openFDA record search
api.fda.gov

Companies that list emtricitabine and tenofovir disoproxil fumarate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Amneal Pharmaceuticals NY LLC4tablet, film coatedGeneric drugs (ANDA)August 26, 2018
Gilead Sciences, Inc.4tablet, film coatedNew drug applications (NDA)March 10, 2016
NuCare Pharmaceuticals,Inc.4tablet, film coatedGeneric drugs (ANDA)March 9, 2022
Zydus Lifesciences Limited4tablet, film coatedGeneric drugs (ANDA)July 1, 2021
Zydus Pharmaceuticals USA Inc.4tablet, film coatedGeneric drugs (ANDA)July 1, 2021
A-S Medication Solutions3tablet, film coatedGeneric drugs (ANDA)March 9, 2022
Aurobindo Pharma Limited3tablet, film coatedGeneric drugs (ANDA)March 9, 2023
Cipla USA Inc.2tablet, film coatedGeneric drugs (ANDA)November 1, 2021
Amneal Pharmaceuticals NY LLC1tablet, film coatedGeneric drugs (ANDA)August 26, 2018
Aurobindo Pharma Limited1tablet, film coatedGeneric drugs (ANDA)March 30, 2021
AvKARE1tablet, film coatedGeneric drugs (ANDA)July 1, 2025
Bryant Ranch Prepack1tablet, film coatedGeneric drugs (ANDA)July 26, 2019
Camber Pharmaceuticals, Inc.1tablet, film coatedGeneric drugs (ANDA)October 7, 2021
Direct_Rx1tablet, film coatedGeneric drugs (ANDA)January 26, 2022
Exelan Pharmaceuticals Inc.1tablet, film coatedGeneric drugs (ANDA)April 6, 2021
Golden State Medical Supply, Inc.1tabletGeneric drugs (ANDA)January 13, 2021
Laurus Labs Limited1tablet, film coatedGeneric drugs (ANDA)July 26, 2019
Lupin Pharmaceuticals, Inc.1tablet, film coatedGeneric drugs (ANDA)June 23, 2021
Macleods Pharmaceuticals Limited1tablet, film coatedGeneric drugs (ANDA)May 15, 2020
Major Pharmaceuticals1tablet, film coatedGeneric drugs (ANDA)July 26, 2019
NorthStar Rx LLC1tablet, film coatedGeneric drugs (ANDA)March 9, 2022
Proficient Rx LP1tablet, film coatedGeneric drugs (ANDA)October 7, 2021
Proficient Rx LP1tablet, film coatedGeneric drugs (ANDA)March 30, 2021
Quallent Pharmaceuticals Health LLC1tablet, film coatedGeneric drugs (ANDA)September 1, 2023
Redpharm Drug1tablet, film coatedGeneric drugs (ANDA)October 7, 2021
Strides Pharma Inc.1tabletGeneric drugs (ANDA)March 30, 2021
Strides Pharma Science Limited1tabletGeneric drugs (ANDA)March 30, 2021
Teva Pharmaceuticals USA, Inc.1tablet, film coatedGeneric drugs (ANDA)January 20, 2021

Dosage forms

Dosage formProductsShare
Tablet, film coated4593.8%
Tablet36.2%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)4389.6%
New drug applications (NDA)510.4%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.